Keyphrases
Anthracyclines
100%
In Cancer
100%
Cancer Patients
100%
Cardiotoxicity
100%
Anthracycline Chemotherapy
100%
Dosage Schedule
100%
Infusion Duration
70%
Peak Dose
40%
Confidence Interval
30%
Randomized Controlled Trial
30%
Meta-analysis
20%
Heart Failure
20%
Response Rate
20%
Adverse Effects
20%
Treatment Group
20%
Subclinical Cardiac Dysfunction
20%
Solid Tumors
10%
Selection Criteria
10%
Overall Survival
10%
Cochrane Library
10%
Embase
10%
Childhood Leukemia
10%
MEDLINE
10%
Data Extraction
10%
Cochrane
10%
Quality Assessment
10%
Low Dose Rate
10%
Patients Included
10%
Ongoing Trials
10%
Conference Proceedings
10%
Short Infusion
10%
Issue 2
10%
Search Strategy
10%
Pooled Study
10%
Dose Duration
10%
Small Data
10%
Nursing and Health Professions
Malignant Neoplasm
100%
Anthracycline
100%
Cardiotoxicity
100%
Drug Dose Regimen
100%
Infusion
58%
Confidence Interval
25%
Meta Analysis
16%
Adverse Event
16%
Congestive Heart Failure
16%
Heart Injury
16%
Data Extraction
8%
Quality Control
8%
Overall Survival
8%
Cochrane Library
8%
Solid Malignant Neoplasm
8%
Leukemia
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Anthracycline
100%
Chemotherapy
100%
Cardiotoxicity
100%
Randomized Controlled Trial
25%
Adverse Event
16%
Congestive Heart Failure
16%
Heart Injury
16%
Solid Malignant Neoplasm
8%
Overall Survival
8%
Leukemia
8%